Based on the Merck & Company Inc stock forecast from 10 analysts, the average analyst target price for Merck & Company Inc is USD 143.94 over the next 12 months. Merck & Company Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Merck & Company Inc is Bearish, which is based on 1 positive signals and 3 negative signals. At the last closing, Merck & Company Inc’s stock price was USD 98.36. Merck & Company Inc’s stock price has changed by -2.78% over the past week, -10.33% over the past month and -3.73% over the last year.
No recent analyst target price found for Merck & Company Inc
No recent average analyst rating found for Merck & Company Inc
Company Overview Merck & Company Inc
N/A
N/A
N/A
N/A
USD
USA
Adjusted Closing Price for Merck & Company Inc (MRK)
Loading...
Unadjusted Closing Price for Merck & Company Inc (MRK)
Loading...
Share Trading Volume for Merck & Company Inc Shares
Frequently Asked Questions About Merck & Company Inc (MRK) Stock
Based on ratings from 10 analysts Merck & Company Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 15 buy, sell and 3 hold ratings.
Unfortunately we do not have enough data on MRK's stock to indicate if its a good dividend stock.
Based on targets from 10 analysts, the average taret price for MRK is USD 143.94 over the next 12 months. The maximum analyst target price is USD 155 while the minimum anlayst target price is USD 125.
Unfortunately we do not have enough data on MRK's stock to indicate if its overvalued.
The last closing price of MRK's stock was USD 98.36.
Unfortunately we do not currently have any market capitalization data for MRK's stock.
Based on targets from 10 analysts, the average taret price for MRK is projected at USD 143.94 over the next 12 months.
This means that MRK's stock price may go up by +46.34% over the next 12 months.
We can't find any ETFs which contains Merck & Company Inc's stock.
Sorry, we do not have any data on the number of employees for Merck & Company Inc.
Sorry we do not have any infomation available on Merck & Company Inc's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
What not to like
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Merck & Company Inc (MRK) Stock
Based on ratings from 10 analysts Merck & Company Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 15 buy, sell and 3 hold ratings.
Unfortunately we do not have enough data on MRK's stock to indicate if its a good dividend stock.
Based on targets from 10 analysts, the average taret price for MRK is USD 143.94 over the next 12 months. The maximum analyst target price is USD 155 while the minimum anlayst target price is USD 125.
Unfortunately we do not have enough data on MRK's stock to indicate if its overvalued.
The last closing price of MRK's stock was USD 98.36.
Unfortunately we do not currently have any market capitalization data for MRK's stock.
Based on targets from 10 analysts, the average taret price for MRK is projected at USD 143.94 over the next 12 months.
This means that MRK's stock price may go up by +46.34% over the next 12 months.
We can't find any ETFs which contains Merck & Company Inc's stock.
Sorry, we do not have any data on the number of employees for Merck & Company Inc.
Sorry we do not have any infomation available on Merck & Company Inc's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for MRK !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
